BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33419840)

  • 1. The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
    Scheipner L; Smolle MA; Barth D; Posch F; Stotz M; Pichler M; StÖger H; Gerger A; Riedl JM
    Anticancer Res; 2021 Jan; 41(1):429-436. PubMed ID: 33419840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
    Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
    PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
    Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
    Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
    BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
    Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
    Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment.
    Kang M; Shin SJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SI
    Dis Markers; 2020; 2020():8887605. PubMed ID: 32724485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
    Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
    Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
    Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
    Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.
    Canat L; Ataly HA; Agalarov S; Alkan I; Altunrende F
    Int Braz J Urol; 2018; 44(2):288-295. PubMed ID: 29211398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
    Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
    Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.
    Zhang LX; Lv Y; Xu AM; Wang HZ
    BMC Cancer; 2019 Aug; 19(1):841. PubMed ID: 31455253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
    BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Sansa A; Venegas MDP; Valero C; Pardo L; Avilés-Jurado FX; Terra X; Quer M; León X
    Head Neck; 2021 Jul; 43(7):2091-2100. PubMed ID: 33675096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer.
    Knittelfelder O; Delago D; Jakse G; Reinisch S; Partl R; Stranzl-Lawatsch H; Renner W; Langsenlehner T
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33228184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma.
    Chen SL; Li JP; Li LF; Zeng T; He X
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.